Abiopharma

Sunrun Reports First Quarter 2026 Financial Results

Permian Resources Declares Quarterly Cash Dividend

argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer

Fluor to Participate in Upcoming Investor Conferences

BridgeBio to Participate in May and June Investor Conferences

Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results

MannKind Reports First Quarter 2026 Financial Results and Provides Business Update

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

Quanterix Releases Financial Results for the First Quarter of 2026